VOYDEYA 50 mg + 100 mg, film-coated tablet 90 tablets
Active ingredients: DANICOPAN
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet90 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VOYDEYA 50 mg + 100 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé et comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 1 flacon polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 90 comprimés de 50 mg + 1 flacon polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 90 comprimés de 100 mg
- Marketing authorisation holder
- ALEXION EUROPE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 3 Feb 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
62480378CIP73029790CIP133400930297902Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DANICOPANcomprimé 100 mg | 100 mg · un comprimé | SA |
| DANICOPANcomprimé 50 mg | 50 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.